ArticleRadiation oncology (London, England)2022

The long-term survival of the doublet regimen of concurrent chemoradiation therapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective study.

Zhi-Qiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.